SEC Form 4 · accession 0000911916-17-000165
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David C Dvorak
Officer — President and CEO · Director
Period of report
Apr 27, 2017
Accepted (ET)
May 1, 2017 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 27, 2017 | M | 100,000 | $88.76 | A | 381,886 | D | |
| Common StockF2,F3 | Apr 27, 2017 | S | 52,784 | $116.13 | D | 329,102 | D | |
| Common StockF2,F4 | Apr 27, 2017 | S | 34,547 | $116.99 | D | 294,555 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $88.76 | Apr 27, 2017 | M | 100,000 | D | — | Apr 30, 2017 | Common Stock | 100,000 | 0 | D |
Explanation of responses
- F1Securities acquired pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.
- F2Securities sold to cover option exercise cost, taxes and fess pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.
- F3Represents the sale of 52,784 shares in multiple transactions, ranging in price from $115.46 to $116.45 per share, resulting in a weighted average sale price of $116.13. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F4Represents the sale of 34,547 shares in multiple transactions, ranging in price from $116.46 to $117.07 per share, resulting in a weighted average sale price of $116.99. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F5Vested annually over four years in increments of 25% each year, commencing on May 1, 2008.